Page last updated: 2024-08-21

maleimide and Colorectal Neoplasms

maleimide has been researched along with Colorectal Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chantima, W; Dharakul, T; Jarussophon, S; Khantasup, K; Saiviroonporn, P1
Begent, RH; Casey, JL; Chaplin, LC; Green, AJ; Hope-Stone, LD; King, DJ; Napier, MP; Pedley, RB; Skelton, L; Weir, N; Yarranton, GT1

Trials

1 trial(s) available for maleimide and Colorectal Neoplasms

ArticleYear
Tumour targeting of humanised cross-linked divalent-Fab' antibody fragments: a clinical phase I/II study.
    British journal of cancer, 2002, May-06, Volume: 86, Issue:9

    Topics: Area Under Curve; Colorectal Neoplasms; Half-Life; Humans; Immunoglobulin Fab Fragments; Maleimides; Radioimmunotherapy; Radionuclide Imaging

2002

Other Studies

1 other study(ies) available for maleimide and Colorectal Neoplasms

ArticleYear
Anti-EpCAM scFv gadolinium chelate: a novel targeted MRI contrast agent for imaging of colorectal cancer.
    Magma (New York, N.Y.), 2018, Volume: 31, Issue:5

    Topics: Binding Sites; Cell Line, Tumor; Chelating Agents; Colorectal Neoplasms; Contrast Media; Dose-Response Relationship, Drug; Epithelial Cell Adhesion Molecule; Gadolinium; Gadolinium DTPA; HEK293 Cells; Humans; Immunoglobulin Fragments; Magnetic Resonance Imaging; Maleimides; Microscopy, Confocal; Protein Domains; Reproducibility of Results

2018